HRMY icon

Harmony Biosciences
HRMY

Upgrade to unlock
Buy
Hold
Sell

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$42
42% upside
High target

5 analyst ratings

positive
2  neutral
40%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
25 Feb ‘26 1 month ago
HC Wainwright & Co
HC Wainwright & Co
Patrick Trucchio
25% 1-yr HRMY win rate
25 Feb ‘26 1 month ago
BofA Securities
BofA Securities
Jason Gerberry
100% 1-yr HRMY win rate
25 Feb ‘26 1 month ago
Needham
Needham
Ami Fadia
71% 1-yr HRMY win rate
25 Feb ‘26 1 month ago
UBS
UBS
Ashwani Verma
50% 1-yr HRMY win rate
11 Feb ‘26 2 months ago